HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lethal hepatitis after gene transfer of IL-4 in the liver is independent of immune responses and dependent on apoptosis of hepatocytes: a rodent model of IL-4-induced hepatitis.

Abstract
The putative role of IL-4 in human and animal models of hepatitis has not yet been directly determined. We now report that direct expression of IL-4 in the liver of rats or mice using recombinant adenoviruses coding for rat or mouse IL-4 (AdrIL-4 and AdmIL-4, respectively) results in a lethal, dose-dependent hepatitis. The hepatitis induced by IL-4 was characterized by hepatocyte apoptosis and a massive monocyte/macrophage infiltrate. IL-4-induced hepatitis was independent of T cell-mediated immune responses. Hepatitis occurred even after gene transfer of IL-4 into nude rats, CD8-depleted rats, cyclosporine A-treated rats, or recombinase-activating gene 2(-/-) immunodeficient mice. Peripheral depletion of leukocytes using high doses of cyclophosphamide, and/or the specific depletion of liver macrophages with liposome-encapsulated dichloromethylene diphosphonate in rats did not block lethal IL-4-induced hepatitis. Direct transduction of hepatocytes with adenoviruses was not essential, since injection of AdrIL-4 into the hind limb induced an identical hepatitis. Finally, primary rat hepatocytes in culture also showed apoptosis when cultured in the presence of rIL-4. IL-4-dependent hepatitis was associated with increases in the intrahepatic levels of IFN-gamma, TNF-alpha, and Fas ligand. Administration of AdmIL-4 to IFN-gamma, TNF-alpha receptor type I, or TNF-alpha receptor type II knockout mice also resulted in lethal hepatitis, whereas a moderate protection was observed in Fas-deficient lpr mice. IL-4-dependent hepatocyte apoptosis could be abolished by treatment with caspase inhibitory peptides. Our results thus demonstrate that IL-4 causes hepatocyte apoptosis, which is only partially dependent on the activation of Apo-1-Fas signaling and is largely independent of any immune cells in the liver.
AuthorsC Guillot, H Coathalem, J Chetritt, A David, P Lowenstein, E Gilbert, L Tesson, N van Rooijen, M C Cuturi, J P Soulillou, I Anegon
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 166 Issue 8 Pg. 5225-35 (Apr 15 2001) ISSN: 0022-1767 [Print] United States
PMID11290807 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amino Acid Chloromethyl Ketones
  • Caspase Inhibitors
  • Cysteine Proteinase Inhibitors
  • FASLG protein, human
  • Fas Ligand Protein
  • Fasl protein, mouse
  • Faslg protein, rat
  • Membrane Glycoproteins
  • N-acetyl-tyrosyl-valyl-alanyl-aspartyl chloromethyl ketone
  • Tumor Necrosis Factor-alpha
  • Interleukin-4
  • Interferon-gamma
Topics
  • Acute Disease
  • Adenoviridae (genetics, immunology)
  • Amino Acid Chloromethyl Ketones (therapeutic use)
  • Animals
  • Apoptosis (drug effects, immunology)
  • Caspase Inhibitors
  • Cell Movement (immunology)
  • Cysteine Proteinase Inhibitors (therapeutic use)
  • Fas Ligand Protein
  • Gene Transfer Techniques
  • Genetic Vectors (administration & dosage, immunology)
  • Hepatitis, Viral, Animal (genetics, immunology, mortality, pathology)
  • Hepatocytes (immunology, pathology)
  • Immunity, Cellular (genetics)
  • Interferon-gamma (biosynthesis)
  • Interleukin-4 (administration & dosage, biosynthesis, genetics, physiology)
  • Kupffer Cells (immunology, virology)
  • Leukocytes (pathology)
  • Liver (drug effects, enzymology, immunology, pathology)
  • Male
  • Membrane Glycoproteins (biosynthesis)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred DBA
  • Mice, Knockout
  • Rats
  • Rats, Nude
  • Rats, Wistar
  • T-Lymphocytes (immunology, virology)
  • Transduction, Genetic
  • Tumor Necrosis Factor-alpha (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: